ImunoTera Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

ImunoTera General Information

Description

Developer of a therapeutic vaccine intended to diagnose the stages of cervical cancer caused by Human papillomavirus. The company's vaccine injects a protein that targets precancerous lesions and HPV-related cancers to treat lesions and cervical cancer, enabling healthcare providers and clinical practices in the allergy and immunology market to standardise care delivery, tailor therapies to individual patient profiles, and manage long-term treatment outcomes within regulated medical settings.

Contact Information

Website
www.imunotera.com.br
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Rua Comendador Elias Jafet
  • 755 Morumbi
  • Sao Paulo
  • Brazil
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • Rua Comendador Elias Jafet
  • 755 Morumbi
  • Sao Paulo
  • Brazil

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImunoTera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 01-Oct-2024 Completed Generating Revenue
8. Accelerator/Incubator 27-Oct-2022 Completed Generating Revenue
7. Accelerator/Incubator 20-May-2021 Completed Generating Revenue
6. Accelerator/Incubator 01-Mar-2021 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
4. Grant Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 01-Jan-2016 Completed Generating Revenue
To view ImunoTera’s complete valuation and funding history, request access »

ImunoTera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImunoTera Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biominas Brasil Accelerator/Incubator
Eretz.Bio Accelerator/Incubator
BiotechTown Accelerator/Incubator Minority
Female Scale Accelerator/Incubator
Financiadora de Estudos e Projetos Government
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

ImunoTera FAQs

  • When was ImunoTera founded?

    ImunoTera was founded in 2016.

  • Where is ImunoTera headquartered?

    ImunoTera is headquartered in Sao Paulo, Brazil.

  • What is the size of ImunoTera?

    ImunoTera has 5 total employees.

  • What industry is ImunoTera in?

    ImunoTera’s primary industry is Drug Discovery.

  • Is ImunoTera a private or public company?

    ImunoTera is a Private company.

  • What is ImunoTera’s current revenue?

    The current revenue for ImunoTera is .

  • How much funding has ImunoTera raised over time?

    ImunoTera has raised $24.3K.

  • Who are ImunoTera’s investors?

    Biominas Brasil, Eretz.Bio, BiotechTown, Female Scale, and Financiadora de Estudos e Projetos are 5 of 9 investors who have invested in ImunoTera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process